Technical Analysis for CPIX - Cumberland Pharmaceuticals Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| See historical CPIX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jan 18 | Stochastic Buy Signal | Bullish | 0.00% |
| Jan 18 | Doji - Bullish? | Reversal | 0.00% |
| Jan 18 | Lower Bollinger Band Touch | Weakness | 0.00% |
| Jan 18 | Oversold Stochastic | Weakness | 0.00% |
| Jan 17 | Doji - Bullish? | Reversal | 1.92% |
| Jan 17 | Oversold Stochastic | Weakness | 1.92% |
| Jan 16 | 200 DMA Resistance | Bearish | -2.67% |
| Jan 16 | Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -2.67% |
| Jan 16 | Oversold Stochastic | Weakness | -2.67% |
| Jan 15 | Narrow Range Bar | Range Contraction | 0.28% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2019-03-05
- Sector: Healthcare
- Industry: Generic Pharmaceuticals
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United States. Its principal products include Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. It also develops Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome. The company markets and sells its products through sales representatives and managers. Cumberland Pharmaceuticals, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more CPIX news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 7.29 |
| 52 Week Low | 5.06 |
| Average Volume | 8,810 |
| 200-Day Moving Average | 6.037 |
| 50-Day Moving Average | 6.2229 |
| 20-Day Moving Average | 6.1542 |
| 10-Day Moving Average | 6.0194 |
| Average True Range | 0.4644 |
| ADX | 9.71 |
| +DI | 13.7595 |
| -DI | 15.5527 |
| Chandelier Exit (Long, 3 ATRs ) | 5.5968 |
| Chandelier Exit (Short, 3 ATRs ) | 6.9332 |
| Upper Bollinger Band | 6.677 |
| Lower Bollinger Band | 5.6314 |
| Percent B (%b) | 0.19 |
| BandWidth | 16.990023 |
| MACD Line | -0.0891 |
| MACD Signal Line | -0.0393 |
| MACD Histogram | -0.0498 |
| Fundamentals | Value |
|---|---|
| Market Cap | 92.67 Million |
| Num Shares | 15.9 Million |
| EPS | -0.44 |
| Price-to-Earnings (P/E) Ratio | -13.25 |
| Price-to-Sales | 3.18 |
| Price-to-Book | 1.73 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.49 | ||||
| Resistance 3 (R3) | 6.47 | 6.22 | 6.38 | ||
| Resistance 2 (R2) | 6.22 | 6.06 | 6.24 | 6.34 | |
| Resistance 1 (R1) | 6.03 | 5.95 | 6.13 | 6.05 | 6.31 |
| Pivot Point | 5.78 | 5.78 | 5.83 | 5.80 | 5.78 |
| Support 1 (S1) | 5.59 | 5.62 | 5.69 | 5.61 | 5.35 |
| Support 2 (S2) | 5.34 | 5.51 | 5.36 | 5.32 | |
| Support 3 (S3) | 5.15 | 5.34 | 5.28 | ||
| Support 4 (S4) | 5.17 |
